Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...

SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Please provide your email address to receive an email when new articles are posted on . Among patients with asthma, those with chronic cough vs. without chronic cough had worse respiratory symptoms, ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

New research from the La Jolla Institute for Immunology has brought a novel, long-term treatment for severe asthma a step closer. Building on a decade of work, the new findings present a potential way ...

Adolescents with overweight or obesity and asthma had a lower risk of asthma exacerbations after starting a GLP-1 receptor ...

Chronic asthma often results in scarring of the lung airways (airway fibrosis) and this can cause airway obstruction. The soluble factor TGF-beta-1, produced by inflammatory cells known as eosinophils ...

The treatment, which will be sold under the brand name Exdensur, is an “ultra-long-acting” version of a biologic treatment ...

Early hospital readmissions for patients with asthma and chronic obstructive pulmonary disease (COPD) represent a major economic burden within the healthcare system and recent research found that ...